Asymptomatic Hyperuricemia and Metabolically Unhealthy Obesity: A Cross-Sectional Analysis in the Tianning Cohort
Jia Yu,1,* Hongyan Sun,2,* Jinhua Zhu,3,* Xintong Wei,1 Hongfei Shi,2 Bin Shen,3 Liyun Ren,1 Yan He,1 Rongyan Zhang,3 Mingzhi Zhang,1 Hao Peng1,4 1Department of Epidemiology, School of Public Health, Medical College of Soochow University, Suzhou, People’s Republic of China; 2Center for Dis...
Guardado en:
| Autores principales: | , , , , , , , , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Dove Medical Press
2021
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/fe019dd5ddcb4cdeafb20bac380800c6 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| id |
oai:doaj.org-article:fe019dd5ddcb4cdeafb20bac380800c6 |
|---|---|
| record_format |
dspace |
| spelling |
oai:doaj.org-article:fe019dd5ddcb4cdeafb20bac380800c62021-12-02T16:34:29ZAsymptomatic Hyperuricemia and Metabolically Unhealthy Obesity: A Cross-Sectional Analysis in the Tianning Cohort1178-7007https://doaj.org/article/fe019dd5ddcb4cdeafb20bac380800c62021-03-01T00:00:00Zhttps://www.dovepress.com/asymptomatic-hyperuricemia-and-metabolically-unhealthy-obesity-a-cross-peer-reviewed-article-DMSOhttps://doaj.org/toc/1178-7007Jia Yu,1,* Hongyan Sun,2,* Jinhua Zhu,3,* Xintong Wei,1 Hongfei Shi,2 Bin Shen,3 Liyun Ren,1 Yan He,1 Rongyan Zhang,3 Mingzhi Zhang,1 Hao Peng1,4 1Department of Epidemiology, School of Public Health, Medical College of Soochow University, Suzhou, People’s Republic of China; 2Center for Disease Prevention and Control of Tianning District, Changzhou, People’s Republic of China; 3Center for Disease Prevention and Control of Wujiang District, Suzhou, People’s Republic of China; 4Jiangsu Key Laboratory of Preventive and Translational Medicine for Geriatric Diseases, Soochow University, Suzhou, People’s Republic of China*These authors contributed equally to this workCorrespondence: Hao PengDepartment of Epidemiology, School of Public Health, Medical College of Soochow University, 199 Renai Road, Industrial Park, Suzhou, 215123, People’s Republic of ChinaTel +86 512 6588 0078Fax +86 512 6588 0052Email penghao@suda.edu.cnObjective: The relationship between obesity and hyperuricemia has been demonstrated by many studies. However, whether or to what extent metabolic condition influents the association between obesity and hyperuricemia was not clear. Here, we aimed to examine the association between obese-metabolic phenotype and hyperuricemia in a large sample of Chinese adults.Methods: According to BMI and metabolic syndrome, obese-metabolic phenotype was defined as metabolically unhealthy obesity (MUO), metabolically healthy obesity (MHO), metabolically unhealthy non-obesity (MUNO) and metabolically healthy non-obesity (MHNO)in the Tianning cohort (N=5072). We conducted a cross-sectional analysis between obese-metabolic phenotype and hyperuricemia, followed by a Mendelian Randomization analysis using GWAS summary data to confirm the causality between uric acid and BMI.Results: The average level of serum UA showed 41.87-higher μmol/L in participants with MHO (β=41.87, P< 0.001) and 63.18-higher μmol/L in participants with MUO (β=63.18, P< 0.001), compared to those with MHNO. Compared to participants with MHNO, those with MUO had the highest likelihood to have hyperuricemia (OR=4.56, P< 0.001), followed by those with MHO (OR=3.32, P< 0.001). Mendelian randomization analysis indicated that uric acid was more likely to be a consequence of BMI (β=0.059, P=6.54× 10− 154).Conclusion: MUO, in comparison with MHO, was significantly associated with hyperuricemia in Chinese adults.Keywords: metabolic syndrome, obesity, serum uric acid, hyperuricemiaYu JSun HZhu JWei XShi HShen BRen LHe YZhang RZhang MPeng HDove Medical Pressarticlemetabolic syndromeobesityserum uric acidhyperuricemiaSpecialties of internal medicineRC581-951ENDiabetes, Metabolic Syndrome and Obesity: Targets and Therapy, Vol Volume 14, Pp 1367-1374 (2021) |
| institution |
DOAJ |
| collection |
DOAJ |
| language |
EN |
| topic |
metabolic syndrome obesity serum uric acid hyperuricemia Specialties of internal medicine RC581-951 |
| spellingShingle |
metabolic syndrome obesity serum uric acid hyperuricemia Specialties of internal medicine RC581-951 Yu J Sun H Zhu J Wei X Shi H Shen B Ren L He Y Zhang R Zhang M Peng H Asymptomatic Hyperuricemia and Metabolically Unhealthy Obesity: A Cross-Sectional Analysis in the Tianning Cohort |
| description |
Jia Yu,1,* Hongyan Sun,2,* Jinhua Zhu,3,* Xintong Wei,1 Hongfei Shi,2 Bin Shen,3 Liyun Ren,1 Yan He,1 Rongyan Zhang,3 Mingzhi Zhang,1 Hao Peng1,4 1Department of Epidemiology, School of Public Health, Medical College of Soochow University, Suzhou, People’s Republic of China; 2Center for Disease Prevention and Control of Tianning District, Changzhou, People’s Republic of China; 3Center for Disease Prevention and Control of Wujiang District, Suzhou, People’s Republic of China; 4Jiangsu Key Laboratory of Preventive and Translational Medicine for Geriatric Diseases, Soochow University, Suzhou, People’s Republic of China*These authors contributed equally to this workCorrespondence: Hao PengDepartment of Epidemiology, School of Public Health, Medical College of Soochow University, 199 Renai Road, Industrial Park, Suzhou, 215123, People’s Republic of ChinaTel +86 512 6588 0078Fax +86 512 6588 0052Email penghao@suda.edu.cnObjective: The relationship between obesity and hyperuricemia has been demonstrated by many studies. However, whether or to what extent metabolic condition influents the association between obesity and hyperuricemia was not clear. Here, we aimed to examine the association between obese-metabolic phenotype and hyperuricemia in a large sample of Chinese adults.Methods: According to BMI and metabolic syndrome, obese-metabolic phenotype was defined as metabolically unhealthy obesity (MUO), metabolically healthy obesity (MHO), metabolically unhealthy non-obesity (MUNO) and metabolically healthy non-obesity (MHNO)in the Tianning cohort (N=5072). We conducted a cross-sectional analysis between obese-metabolic phenotype and hyperuricemia, followed by a Mendelian Randomization analysis using GWAS summary data to confirm the causality between uric acid and BMI.Results: The average level of serum UA showed 41.87-higher μmol/L in participants with MHO (β=41.87, P< 0.001) and 63.18-higher μmol/L in participants with MUO (β=63.18, P< 0.001), compared to those with MHNO. Compared to participants with MHNO, those with MUO had the highest likelihood to have hyperuricemia (OR=4.56, P< 0.001), followed by those with MHO (OR=3.32, P< 0.001). Mendelian randomization analysis indicated that uric acid was more likely to be a consequence of BMI (β=0.059, P=6.54× 10− 154).Conclusion: MUO, in comparison with MHO, was significantly associated with hyperuricemia in Chinese adults.Keywords: metabolic syndrome, obesity, serum uric acid, hyperuricemia |
| format |
article |
| author |
Yu J Sun H Zhu J Wei X Shi H Shen B Ren L He Y Zhang R Zhang M Peng H |
| author_facet |
Yu J Sun H Zhu J Wei X Shi H Shen B Ren L He Y Zhang R Zhang M Peng H |
| author_sort |
Yu J |
| title |
Asymptomatic Hyperuricemia and Metabolically Unhealthy Obesity: A Cross-Sectional Analysis in the Tianning Cohort |
| title_short |
Asymptomatic Hyperuricemia and Metabolically Unhealthy Obesity: A Cross-Sectional Analysis in the Tianning Cohort |
| title_full |
Asymptomatic Hyperuricemia and Metabolically Unhealthy Obesity: A Cross-Sectional Analysis in the Tianning Cohort |
| title_fullStr |
Asymptomatic Hyperuricemia and Metabolically Unhealthy Obesity: A Cross-Sectional Analysis in the Tianning Cohort |
| title_full_unstemmed |
Asymptomatic Hyperuricemia and Metabolically Unhealthy Obesity: A Cross-Sectional Analysis in the Tianning Cohort |
| title_sort |
asymptomatic hyperuricemia and metabolically unhealthy obesity: a cross-sectional analysis in the tianning cohort |
| publisher |
Dove Medical Press |
| publishDate |
2021 |
| url |
https://doaj.org/article/fe019dd5ddcb4cdeafb20bac380800c6 |
| work_keys_str_mv |
AT yuj asymptomatichyperuricemiaandmetabolicallyunhealthyobesityacrosssectionalanalysisinthetianningcohort AT sunh asymptomatichyperuricemiaandmetabolicallyunhealthyobesityacrosssectionalanalysisinthetianningcohort AT zhuj asymptomatichyperuricemiaandmetabolicallyunhealthyobesityacrosssectionalanalysisinthetianningcohort AT weix asymptomatichyperuricemiaandmetabolicallyunhealthyobesityacrosssectionalanalysisinthetianningcohort AT shih asymptomatichyperuricemiaandmetabolicallyunhealthyobesityacrosssectionalanalysisinthetianningcohort AT shenb asymptomatichyperuricemiaandmetabolicallyunhealthyobesityacrosssectionalanalysisinthetianningcohort AT renl asymptomatichyperuricemiaandmetabolicallyunhealthyobesityacrosssectionalanalysisinthetianningcohort AT hey asymptomatichyperuricemiaandmetabolicallyunhealthyobesityacrosssectionalanalysisinthetianningcohort AT zhangr asymptomatichyperuricemiaandmetabolicallyunhealthyobesityacrosssectionalanalysisinthetianningcohort AT zhangm asymptomatichyperuricemiaandmetabolicallyunhealthyobesityacrosssectionalanalysisinthetianningcohort AT pengh asymptomatichyperuricemiaandmetabolicallyunhealthyobesityacrosssectionalanalysisinthetianningcohort |
| _version_ |
1718383790637711360 |